CARL logo

CARLSMED INC

CARLNASDAQ
🏆 #3001 by market capEarnings Nov 10US Equity
$15.77▲ $0.46 (+3.00%)
🌙 After hours$16.00▲ 1.46%Regular close · extended-hours price shown
🔔
Track CARL
Get earnings, price moves & breaking news on Telegram
Track
24h▲ 3.0%
7d▲ 9.1%
14d▲ 17.3%
30d▲ 11.6%
ytd▲ 28.1%
1y▲ 24.7%
🏦Market Cap
$431M
Small Cap
📈Revenue Growth (YoY)
85.9%
High Growth
📊Gross Margin
76.6%
High
💵FCF Margin
-54.0%
Thin
⚖️P/S Ratio
6.6x
Fair
Otter Score
88
Excellent

Trading Snapshot

Day Range
$15.50 – $16.09
52-Week Range
$8.50 – $17.23
Volume (shares)
58,620
Avg Volume (shares)
—
Shares Outstanding
27.3M
Next Earnings
2026-11-10

Fundamentals Snapshot

Annual Revenue
$51M
Last Q Revenue
$19M
P/E Ratio
-11.3
P/S Ratio
6.6x
EPS (TTM)
$-1.34
Dividend Yield
0.00%
Dilution (1yr)
−46.4%
CARL logo

CARLSMED INC

CARL
Financial Trends
RevenueThe total money the company brought in from sales, before subtracting any costs.
$51M▲ +85.9% YoY
Gross MarginOf every $1 of sales, how much is left after the direct cost of making the product/service. Higher = more efficient.
75.3%▲ +2.0% YoY
Operating IncomeProfit from the core business after operating costs, but before interest and taxes. Negative means the core business isn’t profitable yet.
−$31M▲ +26.7% YoY
Free Cash FlowCash left over after running the business and paying for equipment/capex. Negative means the company is burning cash.
−$30M▲ +15.5% YoY
Shares OutstandingHow many shares exist. Rising means the company is issuing more shares, which dilutes (shrinks) each existing owner’s slice.
14.2M▼ −46.4% YoY
Net CashCash minus total debt. Positive = more cash than debt (financially strong); negative = more debt than cash (net debt).
$68M▲ +$45M YoY
StockOtter · stockotter.space

About CARLSMED INC

Carlsmed, Inc., a commercial-stage medical technology company, designs, manufactures, and markets AI-enabled personalized spine surgery solutions. The company develops aprevo, a comprehensive technology platform for spine fusion surgery procedures. Its aprevo platform includes proprietary surgical planning software, using outcomes-based algorithms that are aided with artificial intelligence, and resulting custom-built, anatomically designed vertebral interbody implants. The company was incorporated in 2018 and is based in Carlsbad, California.

🦦

Otter Score Breakdown

How it's scoredFive components, each rated 1–5★ and equally weighted (20%), averaged to a 0–100 score:💎 Quality — gross margin🚀 Growth — revenue YoY⚖️ Valuation — P/S ratio⚡ Momentum — 30-day price change💧 Dilution — 1-yr share issuance (buybacks score higher)
💎Quality★★★★★
🚀Growth★★★★★
⚖️Valuation★★★★★
⚡Momentum★★★★★
💧Dilution★★★★★
Overall Score
Excellent
88/100

Analyst Ratings

ⓘ
Consensus
Buy
11 analysts
Strong Buy4
Buy6
Hold1
Sell0
Strong Sell0
Ratings as of Oct 2026

Latest News & Updates

GlobeNewsWire·2d ago

Carlsmed, Inc. to Report Third Quarter 2026 Financial Results on November 10, 2026

CARLSBAD, Calif., Oct. 27, 2026 (GLOBE NEWSWIRE) -- Carlsmed, Inc. (Nasdaq: CARL) (“Carlsmed” or the “Company”), a medical technology company pioneering AI-enabled personalized spine surgery solutions, today announced it

GlobeNewsWire·15d ago

Carlsmed Launches aprevo® Lumbar Bi-lateral Posterior System

CARLSBAD, Calif., Oct. 14, 2026 (GLOBE NEWSWIRE) -- Carlsmed, Inc. (Nasdaq: CARL) (“Carlsmed” or the “Company”), today announced the U.S. commercial launch of its aprevo® Lumbar Bi-lateral Posterior System at the North A

GlobeNewsWire·27d ago

Carlsmed, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

CARLSBAD, Calif., Oct. 02, 2026 (GLOBE NEWSWIRE) -- Carlsmed, Inc. (Nasdaq: CARL) (“Carlsmed” or the “Company”), a medical technology company pioneering AI-enabled personalized spine surgery solutions, today announced th

GlobeNewsWire·28d ago

Carlsmed Appoints Tony Jarc as Chief Product and AI Officer

CARLSBAD, Calif., Oct. 01, 2026 (GLOBE NEWSWIRE) -- Carlsmed, Inc. (Nasdaq: CARL) (“Carlsmed” or the “Company”), a medical technology company pioneering AI-enabled personalized spine surgery solutions, today announced th

GlobeNewsWire·Sep 28

Carlsmed Appoints Richard Heppenstall as Chief Financial Officer

CARLSBAD, Calif., Sept. 28, 2026 (GLOBE NEWSWIRE) -- Carlsmed, Inc. (Nasdaq: CARL) (“Carlsmed” or the “Company”), a medical technology company pioneering AI-enabled personalized spine surgery solutions, today announced t

GlobeNewsWire·Sep 15

Carlsmed, Inc. Files Patent Infringement Lawsuit against DeGen Medical

CARLSBAD, Calif., Sept. 15, 2026 (GLOBE NEWSWIRE) -- Carlsmed, Inc. (Nasdaq: CARL) (“Carlsmed” ), a medical technology company pioneering AI-enabled personalized spine surgery solutions, today filed a patent infringement